Adult ADHD: A new disease?

References

• Adamou M, Arif M, Asherson P, Aw T-C, Bolea B, Coghill D, et al. 2013. Occupational issues of adults with ADHD. BMC Psychiatry 13:59.
   PubMed Web of Science ®Google Scholar
• Adler L, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, et al. 2008. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 69:1364–1373.
   PubMed Web of Science ®Google Scholar
• Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, et al. 2009. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 26:212–221.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Association.
   Google Scholar
• Asherson P, Bushe C, Saylor K, Tanaka Y, Deberdt W, Upadhyaya H. Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trials. J Psychopharmacol 28:837–846.
   PubMed Web of Science ®Google Scholar
• Arnsten AF, Scahill L, Findling RL. 2007. alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data. J Child Adolesc Psychopharmacol 17:393–406.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Brown TE. 2008. Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr 13:977–984.
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, Fletcher K. 2006. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45:192–202.
   PubMed Web of Science ®Google Scholar
• Bell AS. 2011. A critical review of ADHD diagnostic criteria: what to address in the DSM-V. J Atten Disord 15:3–10.
   PubMed Web of Science ®Google Scholar
• Biederman J, Boellner SW, Childress A, Lopez FA, Krishnan S, Zhang Y. 2007. Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. Biol Psychiatry 62:970–976.
   PubMed Web of Science ®Google Scholar
• Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Spencer T, et al. 2010. A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 30:549–553.
   PubMed Web of Science ®Google Scholar
• Brod M, Pohlman B, Lasser R, Hodgkins P. 2012. Comparison of the burden of illness for adults with ADHD across seven countries: a qualitative study. Health Qual Life Outcomes 10:47. DOI: 10.1186/1477-7525-10-47.
   PubMed Web of Science ®Google Scholar
• Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, et al. 2002. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699–711.
   PubMed Web of Science ®Google Scholar
• Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M. 2011. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Cochrane Database Syst Rev. CD007813. DOI: 10.1002/14651858.CD007813.pub2.
   Google Scholar
• Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, et al. 2011. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 25:157–169.
   PubMed Web of Science ®Google Scholar
• Cunill R, Castells X, Tobias A, Capellà D. 2013. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression. Pharmacoepidemiol Drug Saf 22:961–969.
   PubMed Web of Science ®Google Scholar
• Dalsgaard S. 2013. Attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 22Suppl 1:S43–S48.
   Web of Science ®Google Scholar
• Dulcan M. 1997. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 36:85S–121S.
   Web of Science ®Google Scholar
• DuPaul GJ, Weyandt LL, O’Dell SM, Varejao M. 2009. College students with ADHD: current status and future directions. J Atten Disord 13:234–250.
   PubMed Web of Science ®Google Scholar
• Durell TM, Adler LA, Williams DW, Deldar A, McGough JJ, Fox BK, et al. 2014. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol 33:45–54.
   Web of Science ®Google Scholar
• Faraone SV, Biederman J, Feighner JA, Monuteaux MC. 2000. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol 68:830–842.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, et al. 2006. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry 163:1720–1729.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Glatt SJ. 2010. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 71:754–763.
   PubMed Web of Science ®Google Scholar
• Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2:104–113.
   PubMedGoogle Scholar
• Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. 2004. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 24:24–29.
   PubMed Web of Science ®Google Scholar
• Faraone SV. 2007. Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release). Expert Opin Pharmacother 8:2127–2134.
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, et al. 2007. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 190:402–409.
   PubMed Web of Science ®Google Scholar
• Findling RL, Schwartz MA, Flannery DJ, Manos MJ. 1996. Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial. J Clin Psychiatry 57:184–189.
   PubMed Web of Science ®Google Scholar
• Fischer M, Barkley RA, Smallish L, Fletcher K. 2007. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes. Accid Anal Prev 39:94–105.
   PubMed Web of Science ®Google Scholar
• Frazier TW, Youngstrom EA, Glutting JJ, Watkins MW. 2007. ADHD and achievement: meta-analysis of the child, adolescent, and adult literatures and a concomitant study with college students. J Learn Disabil 40:49–65.
   PubMed Web of Science ®Google Scholar
• Fredriksen M, Halmøy A, Faraone SV, Haavik J. 2013. Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies. Eur Neuropsychopharmacol 23:508–527.
   PubMed Web of Science ®Google Scholar
• Frodl T. 2010. Comorbidity of ADHD and substance use disorder (SUD): a neuroimaging perspective. J Atten Disord 14:109–120.
   PubMed Web of Science ®Google Scholar
• Gadow KD, Nolan EE, Litcher L, Carlson GA, Panina N, Golovakha E, et al. 2000. Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren. J Am Acad Child Adolesc Psychiatry 39:1520–1527.
   PubMed Web of Science ®Google Scholar
• Gershon J. 2002. A meta-analytic review of gender differences in ADHD. J Atten Disord 5:143–154.
   PubMedGoogle Scholar
• Ginsberg Y, Hirvikoski T, Grann M, Lindefors N. 2012. Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate. Eur Arch Psychiatry Clin Neurosci 262:705–724.
   PubMed Web of Science ®Google Scholar
• Ginsberg Y, Hirvikoski T, Lindefors N. 2010. Attention deficit hyperactivity disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry 10:112.
   PubMed Web of Science ®Google Scholar
• Gjervan B, Torgersen T, Nordahl HM, Rasmussen K. 2012. Functional impairment and occupational outcome in adults with ADHD. J Atten Disord 16:544–552.
   PubMed Web of Science ®Google Scholar
• Van de Glind G, Van Emmerik-van Oortmerssen K, Carpentier PJ, Levin FR, Koeter MWJ, Barta C, et al. 2013. The international ADHD in substance use disorders prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res 22:232–244.
   PubMed Web of Science ®Google Scholar
• Goodman DW. 2007. Lisdexamfetamine dimesylate: the first prodrug stimulant. Psychiatry (Edgmont) 4:39–45.
   PubMedGoogle Scholar
• De Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, et al. 2008. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 65:835–842.
   PubMed Web of Science ®Google Scholar
• Green AL, Rabiner DL. 2012. What do we really know about ADHD in college students? Neurotherapeutics 9:559–568.
   PubMed Web of Science ®Google Scholar
• Habel LA, Cooper WO, Sox CM, Chan KA, Fireman BH, Arbogast PG, et al. 2011. ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA 306:2673–2683.
   PubMed Web of Science ®Google Scholar
• Hill JC, Schoener EP. 1996. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 153:1143–1146.
   PubMed Web of Science ®Google Scholar
• Huss M, Ginsberg Y, Tvedten T, Arngrim T, Philipsen A, Kumar V, et al. 2014. Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial. Adv Ther 31:44–65.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Lane M, Stang PE, Van Brunt DL. 2009. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med 39:137–147.
   PubMed Web of Science ®Google Scholar
• Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, et al. 2010. The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry 167:14–16.
   PubMed Web of Science ®Google Scholar
• Klein RG, Mannuzza S, Olazagasti MAR, Roizen E, Hutchison JA, Lashua EC, et al. 2012. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 69:1295–1303.
   PubMed Web of Science ®Google Scholar
• Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. 2009. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 23:733–744.
   PubMed Web of Science ®Google Scholar
• Kooij SJJ, Bejerot S, Blackwell A, Caci H, Casas-brugué M, Carpentier PJ, et al. 2010. European consensus statement on diagnosis and treatment of adult ADHD: the European Network Adult ADHD. BMC Psychiatry 10:67.
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A. 2012. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav 2:661–677.
   PubMed Web of Science ®Google Scholar
• Maneeton N, Maneeton B, Srisurapanont M, Martin SD. 2011. Bupropion for adults with attention-deficit hyperactivity disorder: meta-analysis of randomized, placebo-controlled trials. Psychiatry Clin Neurosci 65:611–617.
   PubMed Web of Science ®Google Scholar
• Mann N, Bitsios P. 2009. Modafinil treatment of amphetamine abuse in adult ADHD. J Psychopharmacol 23:468–471.
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG. 2000. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 9:711–726.
   PubMed Web of Science ®Google Scholar
• Marchant BK, Reimherr FW, Halls C, Williams ED, Strong RE, Kondo D, et al. 2011. Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. Atten Defic Hyperact Disord 3:237–244.
   PubMedGoogle Scholar
• McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, et al. 2009. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194:273–277.
   PubMed Web of Science ®Google Scholar
• McGough JJ, Barkley RA. 2004. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 161:1948–1956.
   PubMed Web of Science ®Google Scholar
• Mick E, McManus DD, Goldberg RJ. 2013. Meta-analysis of increased heart rate and blood pressure associated with CNS stimulant treatment of ADHD in adults. Eur Neuropsychopharmacol 23:534–541.
   PubMed Web of Science ®Google Scholar
• Minde K, Eakin L, Hechtman L, Ochs E, Bouffard R, Greenfield B, et al. 2003. The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry 44:637–646.
   PubMed Web of Science ®Google Scholar
• Moen MD, Keam SJ. 2009. Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder. CNS Drugs 23:1057–1083.
   PubMed Web of Science ®Google Scholar
• Moffitt TE, Houts R, Asherson P, Belsky DW, Corcoran DL, Caspi A, et al. 2015. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry 172:967–977.
   PubMed Web of Science ®Google Scholar
• Murphy K, Barkley R. 1996. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 37:393–401.
   PubMed Web of Science ®Google Scholar
• Murphy K. 2005. Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. J Clin Psychol 61:607–619.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence (NICE). 2008. Attention deficite hyperactivity disorder: the NICE guidelines on Diagnosis and management of ADHD in children, young people and adults. Available from: http://www.nice.org.uk/guidance/cg72. [last accessed 28 Aug 2015].
   Google Scholar
• Pennick M. 2010. Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine. Neuropsychiatr Dis Treat 6:317–327.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, Caspi A, Houts R, Kollins SH, Rohde LA, Moffitt TE. 2010. Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort. J Am Acad Child Adolesc Psychiatry 49:210–216.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry164:942–948.
   PubMed Web of Science ®Google Scholar
• Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gómez N, et al. 2008. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 22:603–611.
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. 2007. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 68:93–101.
   PubMed Web of Science ®Google Scholar
• Retz W, Stieglitz R-D, Corbisiero S, Retz-Junginger P, Rösler M. 2014. Emotional dysregulation in adult ADHD: what is the empirical evidence? Expert Rev Neurother 12:1241–1251.
   Web of Science ®Google Scholar
• Rosenbloom T, Wultz B. 2011. Thirty-day self-reported risky driving behaviors of ADHD and non-ADHD drivers. Accid Anal Prev 43:128–133.
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Fischer R, Ose C, Alm B, Deckert J, et al. 2010. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. World J Biol Psychiatry 11:709–718.
   PubMed Web of Science ®Google Scholar
• Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, et al. 2004. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci 254:365–371.
   PubMed Web of Science ®Google Scholar
• Sallee FR, Eaton K. 2010. Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD). Expert Opin Pharmacother 11:2549–2556.
   PubMed Web of Science ®Google Scholar
• Santosh PJ, Sattar S, Canagaratnam M. 2011. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults. CNS Drugs 25:737–763.
   PubMed Web of Science ®Google Scholar
• Secnik K, Swensen A, Lage MJ. 2005. Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder. Pharmacoeconomics 23:93–102.
   PubMed Web of Science ®Google Scholar
• Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. 2009. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194:204–211.
   PubMed Web of Science ®Google Scholar
• Sobanski E, Brüggemann D, Alm B, Kern S, Deschner M, Schubert T, et al. 2007. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 257:371–377.
   PubMed Web of Science ®Google Scholar
• Solanto MV. 1998. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94:127–152.
   PubMed Web of Science ®Google Scholar
• Spencer TJ, Adler LA, McGough JJ, Muniz R, Jiang H, Pestreich L. 2007. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 61:1380–1387.
   PubMed Web of Science ®Google Scholar
• Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux P-Y, Secnik K. 2004. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health 35:346.e1–346e.9.
   PubMedGoogle Scholar
• Taylor FB, Russo J. 2001. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 21:223–228.
   PubMed Web of Science ®Google Scholar
• Thomas R, Sanders S, Doust J, Beller E, Glasziou P. 2015. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics 135:e994–e1001.
   PubMed Web of Science ®Google Scholar
• Vaughan B, Fegert J, Kratochvil CJ. 2009. Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder. Expert Opin Pharmacother 10:669–676.
   PubMed Web of Science ®Google Scholar
• Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L. 2009. Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. CNS Spectr 14:573–585.
   PubMed Web of Science ®Google Scholar
• Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV. 2010. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psychiatry 71:381–390.
   PubMed Web of Science ®Google Scholar
• Wender PH, Reimherr FW, Marchant BK, Sanford ME, Czajkowski LA, Tomb DA. 2011. A one year trial of methylphenidate in the treatment of ADHD. J Atten Disord 15:36–45.
   PubMed Web of Science ®Google Scholar
• West P, Sweeting H, Der G, Barton J, Lucas C. 2003. Voice-DISC identified DSM-IV disorders among 15-year-olds in the west of Scotland. J Am Acad Child Adolesc Psychiatry 42:941–949.
   PubMed Web of Science ®Google Scholar
• Wigal T, Brams M, Gasior M, Gao J, Squires L, Giblin J. 2010. Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behav Brain Funct 6:34.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Mick E. 1998. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 7:156–163.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone S V, Warburton R, et al. 1996. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153:1147–1153.
   PubMed Web of Science ®Google Scholar
• Willcutt EG. 2012. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 9:490–499.
   PubMed Web of Science ®Google Scholar
• Wilson JJ, Levin FR. 2005. Attention-deficit/hyperactivity disorder and early-onset substance use disorders. J Child Adolesc Psychopharmacol 15:751–763.
   PubMed Web of Science ®Google Scholar